94-8346. Prospective Grant of Co-Exclusive Patent Licenses  

  • [Federal Register Volume 59, Number 67 (Thursday, April 7, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-8346]
    
    
    [[Page Unknown]]
    
    [Federal Register: April 7, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF COMMERCE
    National Technical Information Service
    
     
    
    Prospective Grant of Co-Exclusive Patent Licenses
    
        This is notice in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 
    404.7(a)(1)(i) that the National Technical Information Service (NTIS), 
    U.S. Department of Commerce, is contemplating the issuance of grant co-
    exclusive licenses in the United States to practice the invention 
    embodied in U.S. Patent No. 4,616,316 (Serial No. 6-458,312), titled 
    ``Medication Compliance Monitoring Device Having Conductive Traces upon 
    a Frangible Backing of a Medication Compartment,'' to Medical 
    MicroSystems, Inc., having a place of business in Clarkson Valley, 
    Missouri, and Medical Technology Systems, Inc., having a place of 
    business in Clearwater, Florida. The patent rights in this invention 
    have been assigned to the United States of America.
        The prospective co-exclusive licenses will be royalty-bearing and 
    will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 
    404.7. The prospective co-exclusive licenses may be granted unless, 
    within sixty days from the date of this published Notice, NTIS receives 
    written evidence and argument which establish that the grant of the 
    licenses would not be consistent with the requirements of 35 U.S.C. 209 
    and 37 CFR 404.7.
        The present invention is a medication compliance monitoring system 
    consisting of a blister pack having an array of plastic blisters 
    defining compartments for medication, with a frangible nonconductive 
    backing sheet having conductive traces behind the compartments which 
    are respectively ruptured when the medication doses are removed. The 
    blister pack is detachably connected to an electronic memory circuit 
    via a multi-terminal male connector tab on the backing sheet, wired to 
    the conductive traces, and a corresponding female connector with 
    terminals wired to the electronic memory circuit. The electronic memory 
    circuit addresses each individual trace periodically at a constant time 
    interval over a predetermined extended period of time to determine if 
    it is intact. The electronic memory circuit detects the ruptures and 
    stores the time data thereof over said extended period of time. During 
    the patient's follow-up visit a microcomputer is employed to retrieve 
    the dose-removal-time data from the memory circuit; it processes the 
    data and provides a display of the compliance information. A socket 
    adapter is used to alternately configure the electronic memory circuit 
    for data acquisition and extraction. The socket adapter is in the form 
    of a multiple-pin jumper plug engageable in a multi-contact socket 
    connected to the memory circuit. Insertion of the plug configures the 
    memory circuit for data acquisition. Removal of the plug configures the 
    memory circuit for data retrieval and processing by the microcomputer. 
    In a typical embodiment there are 42 blisters whose associated 
    conductive traces are addressed every 15 minutes over an extended time 
    period which may be as much as 85 days.
        The availability of S.N. 6-458,312 for licensing was published in 
    the Federal Register Vol. 48, No. 54, p. 11483 (March 18, 1983).
        A copy of the instant patent is available for $3.00 (payable by 
    check or money order) from the Commissioner of Patents and Trademarks, 
    Box 9, Washington, DC 20231.
        Inquiries, comments and other materials relating to the 
    contemplated license must be submitted to Neil L. Mark, Center for the 
    Utilization of Federal Technology, NTIS, Box 1423, Springfield, VA 
    22151. Properly filed competing applications received by the NTIS in 
    response to this notice will be considered as objections to the grant 
    of the contemplated license.
    
    Douglas J. Campion,
    
    Acting Director, Office of Federal Patent Licensing.
    
    [FR Doc. 94-8346 Filed 4-7-94; 8:45 am]
    
    BILLING CODE 3510-04-M
    
    
    

Document Information

Published:
04/07/1994
Department:
National Technical Information Service
Entry Type:
Uncategorized Document
Document Number:
94-8346
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: April 7, 1994